These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9039712)

  • 1. Is hormone replacement therapy prescribed for postmenopausal diabetic women?
    Feher MD; Isaacs AJ
    Br J Clin Pract; 1996 Dec; 50(8):431-2. PubMed ID: 9039712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of hormone replacement therapy among cardiac patients at a Canadian academic centre.
    Wise MR; Stewart DE; Liu P; Abramson BL
    CMAJ; 1999 Jul; 161(1):33-6. PubMed ID: 10420861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in postmenopausal women with diabetes mellitus.
    Thijs A; Stehouwer CD
    Semin Vasc Med; 2002 May; 2(2):215-9. PubMed ID: 16222612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population.
    Chin BS; Futaba K; Jethwa A; Lip GY
    Int J Clin Pract; 2001 Oct; 55(8):515-8. PubMed ID: 11695070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes.
    Corrao G; Zambon A; Nicotra F; Fornari C; La Vecchia C; Mezzanzanica M; Nappi RE; Merlino L; Cesana G
    Maturitas; 2007 Jul; 57(3):315-24. PubMed ID: 17485182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do clinicians prescribe HRT for hypertensive postmenopausal women?
    Lip G; Beevers M; Churchill D; Beevers DG
    Br J Clin Pract; 1995; 49(2):61-4. PubMed ID: 7779644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension.
    Kawecka-Jaszcz K; Czarnecka D; Olszanecka A; Rajzer M; Jankowski P
    J Hum Hypertens; 2002 Jul; 16(7):509-16. PubMed ID: 12080436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
    Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
    Neuner JM; McCarthy EP; Davis RB; Phillips RS
    J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapies in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997.
    MacLennan AH; Wilson DH; Taylor AW
    Med J Aust; 1999 Jun; 170(11):524-7. PubMed ID: 10397042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use, intentions, and beliefs about hormone replacement therapy in women with and without diabetes.
    Huston SA; Kirking DM; Shimp LA
    Maturitas; 2006 Aug; 55(1):58-68. PubMed ID: 16504429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study.
    Faber A; Bouvy ML; Loskamp L; van de Berg PB; Egberts TC; de Jong-van den Berg LT
    Br J Clin Pharmacol; 2005 Dec; 60(6):641-7. PubMed ID: 16305589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should women with diabetes mellitus receive hormone replacement therapy?
    Dunne FP
    Int J Clin Pract; 1997; 51(5):299-303. PubMed ID: 9489089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's concerns with hormone replacement therapy--compliance issues.
    Hammond CB
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):157S-160S. PubMed ID: 7958011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women.
    Sutherland WH; Manning PJ; de Jong SA; Allum AR; Jones SD; Williams SM
    Metabolism; 2001 Mar; 50(3):319-24. PubMed ID: 11230785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.